INC Research, SAS Collaborate to Improve Clinical Trials Outcomes
Leading companies team up on solutions to boost productivity, reduce costs
CARY, N.C.--(BUSINESS WIRE)--INC Research, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, and SAS are working together to improve clinical development risk management and achieve targeted product profiles through analytics. Collaborating with SAS, the leader in health analytics software and services, INC Research will offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency and flexibility. The ultimate goal is to improve a customer's ability to manage risk, control investment and maximize ROI in clinical development.
"In an environment of growing trial complexity and shrinking R&D budgets, our biopharmaceutical customers demand innovative solutions and enhanced efficiencies in drug development"
"In an environment of growing trial complexity and shrinking R&D budgets, our biopharmaceutical customers demand innovative solutions and enhanced efficiencies in drug development," said James Ogle, INC Research Chief Executive Officer. "By joining forces with SAS and its advanced analytics platform, INC Research can help customers better predict commercially successful outcomes earlier in the process to maximize development efforts."
SAS' advanced analytics platform will boost INC Research's ability to optimize clinical trial designs and proactively manage operations. By gaining access to SAS® software through a hosted delivery model, INC Research customers will achieve more rapid and informed decisions, faster time to market, and improved cash flow.
"The opportunity for innovation is significant," said Kecia Serwin, VP and General Manager of Health and Life Sciences at SAS. "Organizations across the pharmaceutical industry seek novel ways to increase productivity, control costs and manage R&D risks. INC Research and SAS believe health analytics can have a meaningful impact today in clinical research."
SAS in Health Analytics
SAS is the industry leader in health analytics software and services, delivering best-in-class solutions for improving medical care, strengthening financial performance, deepening customer relationships, and pursuing medical innovations. All of the top 25 health plans and pharmaceutical companies, and leading contract research organizations, depend on SAS for strategic insights into health outcomes, profitability, and customer preferences and behaviors that produce useful intelligence for business transformation and growth. Please visit SAS® for Life Sciences for more information.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com
About SAS
SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions, SAS helps customers at more than 50,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world THE POWER TO KNOW®. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies. Copyright © 2011 SAS Institute Inc. All rights reserved.
Contacts
SAS
Laura Fleek Brumley, 214-349-6296
[email protected]
Cell: 214-803-6692
Visit the SAS Newsroom
www.sas.com/presscenter